Plug Power (NASDAQ:PLUG) Stock Braces for Cash-Runway Scrutiny as U.S. Markets Close Monday

Plug Power (NASDAQ:PLUG) Stock Braces for Cash-Runway Scrutiny as U.S. Markets Close Monday

Plug Power Inc. is set to deliver its second-quarter results after posting a 5.31% gain on Friday. The stock advanced 5.8% over the past week to close at $2.18. Earnings will be released after Monday’s market close, with a conference call scheduled for 4:30 p.m. EDT.

Latest

Silence Therapeutics Jumps Over 25% After Divesiran Phase 2 Trial Supports 12-Week Dosing

Silence Therapeutics Jumps Over 25% After Divesiran Phase 2 Trial Supports 12-Week Dosing

NEW YORK, Aug. 10, 2026, 4:06 p.m. EDT — Silence Therapeutics plc jumped over 25% in late trading on Monday as the company reported its investigational RNA-interference drug divesiran reached all primary and secondary endpoints in a randomized Phase 2 polycythemia vera trial. While overall efficacy was notable, investors appeared to focus on a less obvious outcome: the therapy showed sustained activity with dosing every 12 weeks.